Taken together, our results suggested that alternative RNA splicing of Nfatc1, driven by Sf3b1 mutation, contributes to the aggressiveness of CLL through isoform-specific activation of mTOR signaling. The gene discussed is NFATC1; the disease is B-cell chronic lymphocytic leukemia.